The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Angiotensin Type 1 Receptor Inhibition Enhances the Extinction of Fear Memory
Open accessAbstract
Background The current effective treatment options for posttraumatic stress disorder (PTSD) are limited, and therefore the need to explore new treatment strategies is critical. Pharmacological inhibition of the renin-angiotensin system is a common approach to treat hypertension, and emerging evidence highlights the importance of this pathway in stress and anxiety. A recent clinical study from our laboratory provides evidence supporting a role for the renin-angiotensin system in the regulation of the stress response in patients diagnosed with PTSD.Methods With an animal model of PTSD and the selective angiotensin receptor type 1 (AT1) antagonist losartan, we investigated the acute and long-term effects of AT1 receptor inhibition on fear memory and baseline anxiety. After losartan treatment, we performed classical Pavlovian fear conditioning pairing auditory cues with footshocks and examined extinction behavior, gene expression changes in the brain, as well as neuroendocrine and cardiovascular responses.Results After cued fear conditioning, both acute and 2-week administration of losartan enhanced the consolidation of extinction memory but had no effect on fear acquisition, baseline anxiety, blood pressure, and neuroendocrine stress measures. Gene expression changes in the brain were also altered in mice treated with losartan for 2 weeks, in particular reduced amygdala AT1 receptor and bed nucleus of the stria terminalis c-Fos messenger RNA levels.Conclusions These data suggest that AT1 receptor antagonism enhances the extinction of fear memory and therefore might be a beneficial therapy for PTSD patients who have impairments in extinction of aversive memories.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, recent evidence from mouse studies implicates the renin–angiotensin system in the regulation of fear and anxiety responses as angiotensin receptor AT1 antagonism with the anti-hypertension drug losartan has been shown to enhance fear extinction learning [extinction recall; (87)].”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [87]
In the citing paper
“In addition, recent evidence from mouse studies implicates the renin–angiotensin system in the regulation of fear and anxiety responses as angiotensin receptor AT1 antagonism with the anti-hypertension drug losartan has been shown to enhance fear extinction learning [extinction recall; (87)].”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mouse brain in stereotaxic coordinates
Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
da Luz, A. C. D. D. S., Dias, G. P., Bevilaqua, M. C. D. N., Cocks, G. D., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 4,015
Trauma and Posttraumatic Stress Disorder in the Community: The 1996 Detroit Area Survey of Trauma
Breslau, N., Kessler, R. C., Chilcoat, H. D., Schultz, L. R., Davis, G. C., & Andreski, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.626 · Cited by 2,407
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Ressler, K. J., Mercer, K. B., Bradley, B., Jovanovic, T., Mahan, A., Kerley, K., Norrholm, S. D., Kilaru, V., Smith, A. K., Myers, A. J., et al. (2011) · Nature · doi:10.1038/nature09856 · Cited by 800
Self-citationHeldt, S. A., Stanek, L., Chhatwal, J. P., & Ressler, K. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001957 · Cited by 684
Self-citationMahan, A. L., & Ressler, K. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.007 · Cited by 643
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Wright, 2008, The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer’s disease, J Renin Angiotensin Aldosterone Syst, 9, 226, 10.1177/1470320308099084 · DOI
Cited by
Sorted by citations
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
Holmes, E. A., Ghaderi, A., Harmer, C. J., Ramchandani, P. G., Cuijpers, P., Morrison, A. P., Roiser, J. P., Bockting, C. L. H., O'Connor, R. C., Shafran, R., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30513-8 · Cited by 624
State-of-the-art and future directions for extinction as a translational model for fear and anxiety
Craske, M. G., Hermans, D., & Vervliet, B. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0025 · Cited by 373
Stein, M. B., Levey, D. F., Cheng, Z., Wendt, F. R., Harrington, K. M., Pathak, G. A., Cho, K., Quaden, R. M., Radhakrishnan, K., Girgenti, M. J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00767-x · Cited by 239
Neuroprotective Effects of Angiotensin Receptor Blockers
Villapol, S., & Saavedra, J. M. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu197 · Cited by 219
Interoceptive pathways to understand and treat mental health conditions
Nord, C. L., & Garfinkel, S. N. (2022) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.03.004 · Cited by 199
Posttraumatic stress disorder: A metabolic disorder in disguise?
Michopoulos, V., Vester, A., & Neigh, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.038 · Cited by 152
Brudey, C., Park, J., Wiaderkiewicz, J., Kobayashi, I., Mellman, T. A., & Marvar, P. J. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00343.2014 · Cited by 137
Self-citationThe Physiology of Fear: Reconceptualizing the Role of the Central Amygdala in Fear Learning
Keifer, O. P., Hurt, R. C., Ressler, K. J., & Marvar, P. J. (2015) · Physiology · doi:10.1152/physiol.00058.2014 · Cited by 124
Self-citationBriscione, M. A., Jovanovic, T., & Norrholm, S. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00088 · Cited by 105
Wang, L. A., de Kloet, A. D., Pati, D., Hiller, H., Smith, J. A., Pioquinto, D. J., Ludin, J. A., Oh, S. P., Katovich, M. J., Frazier, C. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.026 · Cited by 105
FROM THE NEUROBIOLOGY OF EXTINCTION TO IMPROVED CLINICAL TREATMENTS
Morrison, F. G., & Ressler, K. J. (2013) · Depression and Anxiety · doi:10.1002/da.22214 · Cited by 107
Self-citationAugmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders
Lebois, L. A. M., Seligowski, A. V., Wolff, J. D., Hill, S. B., & Ressler, K. J. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095634 · Cited by 97
Self-citationde Kloet, A. D., Wang, L. A., Pitra, S., Hiller, H., Smith, J. A., Tan, Y., Nguyen, D., Cahill, K. M., Sumners, C., Stern, J. E., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3674-16.2017 · Cited by 90
Jaimes, R., Swiercz, A. P., Sherman, M. G., Muselimyan, N., Marvar, P. J., & Posnack, N. G. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2017 · Cited by 88
Self-citationBeneficial effects of Angiotensin II receptor blockers in brain disorders
Saavedra, J. M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.017 · Cited by 81
Zhou, F., Geng, Y., Xin, F., Li, J., Feng, P., Liu, C., Zhao, W., Feng, T., Guastella, A. J., Ebstein, R. P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.007 · Cited by 70
Bukalo, O., Pinard, C. R., & Holmes, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12779 · Cited by 73
Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system
Quitterer, U., & AbdAlla, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.014 · Cited by 67
Salmani, H., Hosseini, M., Baghcheghi, Y., Moradi‐Marjaneh, R., & Mokhtari‐Zaer, A. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154860 · Cited by 53
Involvement of the brain–heart axis in the link between PTSD and cardiovascular disease
Seligowski, A. V., Webber, T. K., Marvar, P. J., Ressler, K. J., & Philip, N. S. (2022) · Depression and Anxiety · doi:10.1002/da.23271 · Cited by 55
Self-citationThe renin–angiotensin system in PTSD: a replication and extension
Seligowski, A. V., Duffy, L., Merker, J. B., Michopoulos, V., Gillespie, C. F., Marvar, P. J., Stein, M. B., & Ressler, K. J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00923-1 · Cited by 52
Self-citationWright, J. W., Kawas, L. H., & Harding, J. W. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.004 · Cited by 51
Nylocks, K. M., Michopoulos, V., Rothbaum, A. O., Almli, L. M., Gillespie, C. F., Wingo, A. P., Schwartz, A. C., Habib, L., Gamwell, K. L., Marvar, P. J., et al. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32313 · Cited by 51
Self-citationEstradiol modulation of the renin–angiotensin system and the regulation of fear extinction
Parrish, J. N., Bertholomey, M. L., Pang, H. W., Speth, R. C., & Torregrossa, M. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0374-0 · Cited by 51
Should losartan be administered following brain injury?
Friedman, A., Bar-Klein, G., Serlin, Y., Parmet, Y., Heinemann, U., & Kaufer, D. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.972945 · Cited by 47
Pulcu, E., Shkreli, L., Holst, C. G., Woud, M. L., Craske, M. G., Browning, M. D., & Reinecke, A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.010 · Cited by 46
How can neurobiology of fear extinction inform treatment?
Craske, M. G., Sandman, C. F., & Stein, M. B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104923 · Cited by 43
Brain angiotensin-(1–7)/Mas axis: A new target to reduce the cardiovascular risk to emotional stress
Fontes, M. A. P., Lima, A. M., & Santos, R. A. S. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.10.003 · Cited by 41
Amygdala-Dependent Molecular Mechanisms of the Tac2 Pathway in Fear Learning
Andero, R., Daniel, S., Guo, J., Bruner, R. C., Seth, S., Marvar, P. J., Rainnie, D. G., & Ressler, K. J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.77 · Cited by 41
Self-citationSeligowski, A. V., Misganaw, B., Duffy, L., Ressler, K. J., & Guffanti, G. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21111113 · Cited by 42
Self-citationWright, J. W., & Harding, J. W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142814 · Cited by 40
Terock, J., Hannemann, A., Janowitz, D., Freyberger, H. J., Felix, S. B., Dörr, M., Nauck, M. A., Völzke, H., & Grabe, H. J. (2018) · Psychological Medicine · doi:10.1017/s0033291718001496 · Cited by 41
Sladek, C. D., Michelini, L. C., Stachenfeld, N. S., Stern, J. E., & Urban, J. H. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140028 · Cited by 51
Hurt, R. C., Garrett, J. C., Keifer, O. P., Linares, A., Couling, L. E., Speth, R. C., Ressler, K. J., & Marvar, P. J. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12235 · Cited by 39
Self-citationAngiotensin Regulation of Amygdala Response to Threat in High-Trait-Anxiety Individuals
Reinecke, A., Browning, M. D., Breteler, J. K., Kappelmann, N., Ressler, K. J., Harmer, C. J., & Craske, M. G. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.05.007 · Cited by 35
Self-citationAngiotensin Receptor Blockers Are Not Just for Hypertension Anymore
Saavedra, J. M. (2021) · Physiology · doi:10.1152/physiol.00036.2020 · Cited by 37
Candesartan ameliorates impaired fear extinction induced by innate immune activation
Quiñones-Cordero, M. M., Maldonado, L., Velázquez, B., & Porter, J. T. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.10.017 · Cited by 39
Stein, M. B., Jain, S., Simon, N. M., West, J. C., Marvar, P. J., Bui, É., He, F., Benedek, D. M., Cassano, P., Griffith, J. L., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.05.012 · Cited by 38
Self-citationYu, Z., Swiercz, A. P., Moshfegh, C. M., Hopkins, L. S., Wiaderkiewicz, J., Speth, R. C., Park, J., & Marvar, P. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.027 · Cited by 32
Self-citationMarvar, P. J., Andero, R., Hurlemann, R., Lago, T. R., Zelikowsky, M., & Dabrowska, J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1647-20.2020 · Cited by 29
Self-citationGasparyan, A., Navarro, D., Navarrete, F., & Manzanares, J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109211 · Cited by 34
Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives
Correa, B. H. M., Becari, L., Fontes, M. A. P., Silva, A. C. S. E., & Kangussu, L. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210719142300 · Cited by 31
Shkreli, L., Woud, M. L., Ramsbottom, R., Rupietta, A. E., Waldhauser, G. T., Kumsta, R., & Reinecke, A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0553-y · Cited by 28
Terock, J., Hannemann, A., Janowitz, D., der Auwera, S. V., Bahls, M., Völzke, H., & Grabe, H. J. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.05.026 · Cited by 27
Fear-Potentiated Behaviour Is Modulated by Central Amygdala Angiotensin II AT1 Receptors Stimulation
Marinzalda, M. D. L. Á., Pérez, P. A., Gargiulo, P. Á., Casarsa, B. S., Bregonzio, C., & Baiardi, G. (2014) · BioMed Research International · doi:10.1155/2014/183248 · Cited by 26
Attilio, P. J., Snapper, D. M., Rusnak, M., Isaac, A. J., Soltis, A. R., Wilkerson, M. D., Dalgard, C. L., & Symes, A. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.636259 · Cited by 26
Molecular signaling pathways underlying schizophrenia
Tiihonen, J., Koskuvi, M., Lähteenvuo, M., Trontti, K., Ojansuu, I., Vaurio, O., Cannon, T. D., Lönnqvist, J. K., Therman, S., Suvisaari, J., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.05.011 · Cited by 25
Targeting the Renin-Angiotensin System (RAS) for Neuropsychiatric Disorders
de Miranda, A. S., Macêdo, D. S., Rocha, N. P., & Teixeira, A. L. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220927093815 · Cited by 24
Smith, J. A., Pati, D., Wang, L. A., de Kloet, A. D., Frazier, C. J., & Krause, E. G. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00046 · Cited by 25
Zhang, R., Zhao, W., Qi, Z., Xu, T., Zhou, F., & Becker, B. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.09.008 · Cited by 21
Neuropsychiatric Properties of the ACE2/Ang-(1-7)/Mas Pathway: A Brief Review
de Melo, L. A., & Almeida-Santos, A. F. (2019) · Protein and Peptide Letters · doi:10.2174/0929866527666191223143230 · Cited by 24
Mohite, S., Sanches, M., & Teixeira, A. L. (2019) · Protein and Peptide Letters · doi:10.2174/0929866527666191223144000 · Cited by 25
Zhou, X., Xu, T., Zeng, Y., Zhang, R., Qi, Z., Zhao, W., Kendrick, K. M., & Becker, B. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1114-22.2022 · Cited by 19
Angiotensin-(1-7)/Mas axis modulates fear memory and extinction in mice
Lazaroni, T. L. D. N., Bastos, C. P., Moraes, M. F. D., Santos, R. A. S., & Pereira, G. S. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.11.012 · Cited by 22
Evaluation of an angiotensin Type 1 receptor blocker on the reconsolidation of fear memory
Swiercz, A. P., Iyer, L., Yu, Z., Edwards, A., Prashant, N. M., Nguyen, B., Horvath, A., & Marvar, P. J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01043-6 · Cited by 21
Self-citationHammoud, M. Z., Foa, E. B., & Milad, M. R. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12800 · Cited by 23
Class A and C GPCR Dimers in Neurodegenerative Diseases
Moreira, I. S., Caniceiro, A. B., Bueschbell, B., & Schiedel, A. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220327221830 · Cited by 18
Xu, T., Zhou, X., Jiao, G., Zeng, Y., Zhao, W., Li, J., Yu, F., Zhou, F., Yao, S., & Becker, B. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.05.007 · Cited by 16
Overexpression of angiotensin converting enzyme 2 reduces anxiety-like behavior in female mice.
de Kloet, A. D., Cahill, K. M., Scott, K. A., & Krause, E. G. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113002 · Cited by 20
Xu, T., Chen, Z., Zhou, X., Wang, L., Zhou, F., Yao, D., Zhou, B., & Becker, B. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306936121 · Cited by 18
Pharmacotherapy for Anxiety Disorders.
O’Leary, K. B., & Khan, J. S. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.04.012 · Cited by 22
Lemche, A. V., Чабан, О., & Lemche, E. (2016) · Psychophysiology · doi:10.1111/psyp.12623 · Cited by 18
Extinction of Fear Memory Attenuates Conditioned Cardiovascular Fear Reactivity
Swiercz, A. P., Seligowski, A. V., Park, J., & Marvar, P. J. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00276 · Cited by 18
Self-citationYu, Z., Kisner, A., Bhatt, A., Polter, A. M., & Marvar, P. J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109460 · Cited by 17
Self-citationPharmacological rewriting of fear memories: A beacon for post-traumatic stress disorder
Uniyal, A., Singh, R., Akhtar, A., Dhaliwal, J., Kuhad, A., & Sah, S. P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172824 · Cited by 19
Honoring the Past, Envisioning the Future: ABCT’s 50th Anniversary Presidential Address
Craske, M. G. (2017) · Behavior Therapy · doi:10.1016/j.beth.2017.05.003 · Cited by 18
PTSD as an Endothelial Disease: Insights From COVID-19
Sfera, A., Osorio, C. P., Rahman, L., del Campo, C. M. Z.-M., Maldonado, J. C., Jafri, N., Cummings, M. A., Maurer, S., & Kozlakidis, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.770387 · Cited by 16
Angiotensin II Signaling and Fear Extinction: Translational Evidence and Novel Receptor Targets
Stout, D. M., & Risbrough, V. B. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.026 · Cited by 16
Shekhar, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.004 · Cited by 17
Genomic Characterization of Posttraumatic Stress Disorder in a Large US Military Veteran SamplePreprint
Stein, M. B., Levey, D. F., Cheng, Z., Wendt, F. R., Harrington, K. M., Cho, K., Quaden, R. M., Radhakrishnan, K., Girgenti, M. J., Ho, Y.-L. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/764001 · Cited by 15
Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches
Bui, É., King, F., & Melaragno, A. (2019) · General Psychiatry · doi:10.1136/gpsych-2019-100136 · Cited by 17
Winter, A., Ahlbrand, R., & Sah, R. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.007 · Cited by 14
Silva, C. C., & Fontes, M. A. P. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.05.014 · Cited by 11
Chen, F.-F., Wang, C., Chen, H., Wang, J., Han, Q.-Q., Cao, Y., Shen, T., Yang, Y., Hu, Z., Wang, F., et al. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147136 · Cited by 9
Enhancing Fear Extinction: Pharmacological Approaches
Ponomareva, O. Y., Fenster, R. J., & Ressler, K. J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_443 · Cited by 7
Self-citationYoo, S., Stremlau, M. H., Pinto, A., Woo, H., Curtis, O., & van Praag, H. (2021) · Cells · doi:10.3390/cells10071778 · Cited by 9
Kang, S., Kim, J., Yang, J. S., Jeon, Y. J., Lee, H., Suglia, S. F., Tsai, A. C., Kang, J. I., & Jung, S. J. (2024) · BMC Medicine · doi:10.1186/s12916-024-03704-5 · Cited by 8
Neural Circuitry of Stress, Fear, and Anxiety
Paul, E. D., & Chen, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00008-5 · Cited by 7
Zika, O., Appel, J. E., Klinge, C., Shkreli, L., Browning, M. D., Wiech, K., & Reinecke, A. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.01.020 · Cited by 6
Ortiz-Nazario, E., Denton-Ortiz, C. M., Soto-Escobar, L. D. M., Mateo-Mayol, Z., Colón-Romero, M., Hernández, A., & Porter, J. T. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114639 · Cited by 6
Choy, K. H. C., Chavez, C. A., Yu, J., & Mayorov, D. N. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.05.004 · Cited by 5
RNA-based drugs: current, imminent and possible therapeutic applications
Torrisi, S. A., Geraci, F., Diolosà, L., Luca, A. D., Falzone, L., Drago, F., Libra, M., & Leggio, G. M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108958 · Cited by 9
Shkreli, L., Thoroddsen, T., Kobelt, M., Martens, M., Browning, M. D., Harmer, C. J., Cowen, P. J., & Reinecke, A. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2023.100286 · Cited by 6
Torregrossa, M. M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.07.009 · Cited by 5
Stress, Angiotensin, and Cognate Receptors
Aguilera, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00024-3 · Cited by 5
Is RAS the Link Between COVID-19 and Increased Stress in Head and Neck Cancer Patients?
Iftikhar, A., Islam, M. R., Shepherd, S. D., Jones, S., & Ellis, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714999 · Cited by 5
Aghaei, I., Arjmand, S., Yousefzadeh-Chabok, S., Tondar, M., & Shabani, M. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000311 · Cited by 5
Renin-angiotensin-aldosterone system activity in a female trauma-exposed sample
Sinnott, S. M., Ellis, R. A., Khawand, A., Marvar, P. J., Stein, M. B., Ressler, K. J., Huffman, J. C., & Seligowski, A. V. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116573 · Cited by 4
Self-citationWang, Y., Takeshita, H., Yamamoto, K. I., Huang, Y., Wang, C., Nakajima, T., Nozato, Y., Fujimoto, T., Yokoyama, S., Hongyo, K., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100016r · Cited by 4
The influence of chromosome 4 on high ethanol consumption and blood pressure
Anjos, P. A. R., Marchette, R. C. N., Kremer, R., Granzotto, N., Alves, T. M., Fadanni, G. P., Mazur, F. G., Anton, E. L., da Silva‐Santos, J. E., Linder, A. E., et al. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.04.004 · Cited by 4
Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders
Towo, D. H. H., Jari, I., Canivet, C., & Deslauriers, J. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111635 · Cited by 3
Outcomes of metabolic syndrome and anxiety levels in light and heavy smokers
Şahin, M., & Yüzügüllü, D. (2025) · PeerJ · doi:10.7717/peerj.19069 · Cited by 5
Antihypertensive Medications and PTSD Incidence in a Trauma Cohort
Gradus, J. L., Smith, M. L., Szentkúti, P., Rosellini, A. J., Horváth–Puhó, E., Lash, T. L., Galea, S., Schnurr, P. P., Sumner, J. A., & Sørensen, H. T. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22m14767 · Cited by 3
Neuropeptidases, Stress, and Memory—A Promising Perspective
Prieto, I., Segarra, A. B., de Gasparo, M., & Ramírez‐Sánchez, M. (2016) · AIMS neuroscience · doi:10.3934/neuroscience.2016.4.487 · Cited by 3
Gomes‐de‐Souza, L., Santana, F. G., Duarte, J. O., Barretto‐de‐Souza, L., & Crestani, C. C. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-023-02791-2 · Cited by 2
Song, J. (2026) · iScience · doi:10.1016/j.isci.2026.115447 · Cited by 3
The renin-angiotensin system, emotional stress and anxiety
Fontes, M. A. P., Kangussu, L. M., & Silva, A. C. S. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99618-1.00030-1 · Cited by 2
Smith, H. C., Yu, Z., Iyer, L., & Marvar, P. J. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100340 · Cited by 2
Self-citationPreliminary study of ovariectomy and chronic losartan-induced alterations in brain AT1 receptors
Mehranfard, D., Linares, A., Chabbra, A., Campos, G. V., de Souza, A. M. A., Ji, H., West, C. A., Sandberg, K. L., & Speth, R. C. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147520 · Cited by 2
Smith, H., Yu, Z., Iyer, L., & Marvar, P. J. (2024) · Physiology · doi:10.1152/physiol.2024.39.s1.1925 · Cited by 2
Self-citation
Metadata
- Authors
- Marvar, P. J., Goodman, J., Fuchs, S., Choi, D. C., Banerjee, S., & Ressler, K. J.
- Affiliations
- Emory University (US)
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 75
- Issue
- 11
- Pages
- 864-872
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC3975818
- OpenAlex
- W2053674362
- Cited by
- 110
- References
- 82
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 17 · 2020: 4 · 2019: 19 · 2018: 5 · 2017: 7 · 2016: 5 · 2015: 11 · 2014: 7
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (P51OD011132)
- National Heart, Lung, and Blood Institute (K99HL107675, R00HL107675)
- National Institute of Mental Health (R01MH096764)
- National Center for Research Resources (P51RR000165)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- angiotensin II type 1 receptor, losartan, fear extinction, post-traumatic stress disorder, renin-angiotensin system, fear conditioning, amygdala, bed nucleus of the stria terminalis, c-fos, anxiety, stress response, cardiovascular response, neuroendocrine response
- MeSH terms
- Animals, Disease Models, Animal, Extinction, Psychological, Fear, Male, Memory, Mice, Inbred C57BL, Stress Disorders, Post-Traumatic, Losartan, Angiotensin II Type 1 Receptor Blockers, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review